Skip to main content

Table 1 Clinical characteristics of the enrolled oncological patients

From: Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans

Characteristics

Full dose (n = 5)

Half dose (n = 5)

Quarter dose (n = 5)

Age (years)

60.2 ± 8.2

53.2 ± 11.01

57.6 ± 7.96

Gender (F/M)

2/3

2/3

1/4

Height (cm)

160.6 ± 7.81

163.1 ± 4.34

164.2 ± 3.76

Weight (kg)

62.52 ± 4.72

63.88 ± 3.16

58.6 ± 5.33

BMI (kg/m2)

24.31 ± 2.00

24.08 ± 1.96

21.76 ± 2.05

Blood glucose level before injection (mmol/L)

6.5 ± 0.78

6.55 ± 0.15

6.13 ± 0.38

Injected dose (MBq)

255.37 ± 36.61

124.83 ± 16.29

65.71 ± 6.79

Histopathology

   

 Lung cancer

4

5

4

 Colon cancer

0

0

1

 Endometrial carcinoma

1

0

0